RE:RE:RE:RE:RE:How LTE suddenly became a cause of failureI absolutely understand what you are saying about confirmation bias and people do need to keep it in check. That's true.
But ...
I look at the chronic pain dilemma a little differently than OTENA being done or being shutdown ... it's evolving.
We are presently waiting for the company to come up with as a regimen to keep the liver enzymes in check while also ensuring enough painkiller in the process.
Let's just assume for a moment ... that with a lot of effort, they get close but not close enough for the regimen to ensure both - liver enzymes in check - and - enough painkilling.
There is an additional angle that would need to be considered (if it isn't already).
Aside from throwing placebo in the mix as a viable dose in the regimen, we could also toss in naproxen pills (or another non-H2S suitable painkiller) into the toolbox.
Then - I see an enless set of combinations an permutations to get to the desired outcome and get us that balancing act that is needed. Sure naproxen pills in the mix isn't ideal but with enough H2S in the system - it seems like a good last-ditch-effort.
So ...
While they figure out the pill order and the full regimen, chasing Acute makes perfect sense as it is faster and easier to the money (IMO).
--------------------
It's 2017 all over again - and I'm just fine watching the chaos.
Note: I am not suggesting you buy or sell shares - I'm giving you my angle and I'm looking for arguments that may indicate my thought process is wrong ... that's all.
: )